Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

13 Aug 2019 15:19

RNS Number : 9065I
Income & Growth VCT (The) PLC
13 August 2019
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2019

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2019. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2019

At 31 March 2019

 

Net assets attributable to shareholders

£84,211,371

£81,438,038

Shares in issue

103,827,380

104,363,865

Net asset value (NAV) per share

81.11p*

78.03p

Cumulative dividends paid to date per share

111.50p*

111.50p

Total return per share since inception (NAV basis)

192.61p

189.53p

*Figures are quoted prior to the 1.50 pence dividend referred to below.

 

INTERIM DIVIDEND

 

The Board declared an interim dividend of 1.50 pence per share for the year ending 30 September 2019, comprising 1.00 penny and 0.50 pence from capital. This dividend was paid to shareholders on 12 July 2019 to shareholders on the Register on 14 June 2019 and brings cumulative dividends paid per share to 113.00 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

SHARE BUYBACKS

 

On 5 June 2019, the Company purchased 300,000 of the Company's own ordinary shares at a price of 67.50 pence per share for cancellation.

 

On 7 June 2019, the Company purchased 236,485 of the Company's own ordinary shares at a price of 70.25 pence for cancellation.

 

After the period end, with effect from 1 August 2019, the Board changed its share buyback policy objective of maintaining the discount to Net Asset Value at which the Company's shares may trade in the market from approximately 10% or less, to approximately 5% or less. In pursuing this policy, the Board's priority will remain to ensure that it is acting prudently and in the interests of the remaining shareholders of the Company. Share buybacks will continue to be entirely at the Board's discretion and will be subject to the Company having sufficient funds available for such a purpose. They will also continue to be subject to prevailing market conditions, the Listing Rules and any applicable law and regulatory restrictions at the relevant time. Shares bought back in the market will ordinarily be cancelled.

 

INVESTMENT ACTIVITY

 

Investments during the period

On 13 May 2019, the Company invested £1.53 million into a new investee company, Arkk Consulting, which provides services and software to enable organisations to remain compliant with regulatory reporting requirements.

 

On 22 May 2019, the Company invested £0.93 million into a new investee company, Parsley Box, which is a UK direct to consumer supplier of home delivered ambient ready meals for the elderly.

 

Realisations during the period

On 10 May 2019, the Company sold its remaining investment in Plastic Surgeon to Polygon Group for £1.22 million. Over the eleven years this investment was held, it generated proceeds of £2.27 million compared to an original investment cost £0.41 million, which is a multiple on cost of 5.6 x and an IRR of 20.5%.

 

On 28 June 2019, the Company sold its investment in ASL Technology for £4.79 million. Over the eight and a half years this investment was held, it generated proceeds of £5.94 million compared to an original investment cost of £2.72 million, which is a multiple on cost of 2.2x and an IRR of 12.6%.

 

Transactions after the period end

After the period end, the Company made a follow-on investment of £0.62 million into MPB Group, a leading online marketplace for camera and video equipment.

 

On 2 August 2019, £0.17 million of contingent consideration was received as part of the sale of Entanet Holdings in August 2017.

On 6 June 2019, the Company realised part of its investment in Master Removers Group generating proceeds receivable of £0.51 million, as part of a transaction which also increased the Company's equity interest from 6.3% to 9.6%.

 

PLANNED FUNDRAISING

As announced recently, the Board intends to launch offers for subscription for new ordinary shares in the autumn, full details of which will be contained in the prospectus that will be sent to all registered shareholders.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Rob Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORSRKKAWAAR
Date   Source Headline
18th Jun 202511:15 amRNSChange of Name
9th Jun 202512:30 pmRNSRealisation of investment in Rota Geek Limited
2nd Jun 20257:00 amRNSRealisation of investment in My Tutorweb Limited
1st May 20257:00 amRNSTotal Voting Rights
11th Apr 20253:49 pmRNSDirector/PDMR Shareholding
11th Apr 20253:12 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20257:00 amRNSTransaction in own shares and Total Voting Rights
6th Mar 20251:23 pmRNSInterim Management Statement
5th Mar 20256:05 pmRNSResult of AGM
5th Mar 20255:17 pmRNSDividend Declaration
3rd Mar 20252:30 pmRNSTotal Voting Rights and Capital
26th Feb 20256:10 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSTotal Voting Rights
21st Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20257:00 amRNSAnnual Financial Report
2nd Dec 20247:00 amRNSTotal Voting Rights and Capital
29th Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20243:10 pmRNSDirector/PDMR Shareholding
18th Oct 20242:58 pmRNSIssue of Equity and Total Voting Rights
17th Oct 20244:26 pmRNSOFFER FOR SUBSCRIPTION - UPDATE
2nd Oct 20247:05 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Equity and Total Voting Rights
26th Sep 20242:23 pmRNSTransaction in Own Shares and Total Voting Rights
18th Sep 202410:00 amRNSOffer for Subscription – Update
12th Sep 20245:31 pmRNSInterim Management Statement
11th Sep 20244:33 pmRNSDividend Declaration
2nd Sep 20243:15 pmRNSOffers for Subscription – Open for Applications
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTotal Voting Rights and Capital
26th Jul 20243:00 pmRNSDirector/PDMR Shareholding
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:30 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:35 amRNSTotal Voting Rights
27th Jun 20248:00 amRNSDirector Declaration
18th Jun 20245:54 pmRNSPROPOSED MERGER AND OFFERS
12th Jun 20244:08 pmRNSHalf-year Report
12th Jun 202410:39 amRNSIssue of Equity and Total Voting Rights
10th Jun 20244:00 pmRNSMerger Proposals/Intention To Launch Joint Offers
7th Jun 202411:05 amRNSDirector/PDMR Shareholding
7th Jun 202410:29 amRNSIssue of Equity and Total Voting Rights
3rd Jun 20242:29 pmRNSNet Asset Value at 31 March 2024
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.